{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T16:31:59Z","timestamp":1783960319487,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.cgh.2006.01.014","type":"journal-article","created":{"date-parts":[[2006,4,7]],"date-time":"2006-04-07T07:23:26Z","timestamp":1144394606000},"page":"442-450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Effect of Tegaserod on Esophageal Pain Threshold, Regurgitation, and Symptom Relief in Patients With Functional Heartburn and Mechanical Sensitivity"],"prefix":"10.1016","volume":"4","author":[{"given":"Sheila","family":"Rodriguez\u2013Stanley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sattar","family":"Zubaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard M.","family":"Proskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Kralstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Shetzline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Philip B.","family":"Miner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2006.01.014_bib1","doi-asserted-by":"crossref","first-page":"A151","DOI":"10.1016\/0016-5085(95)23268-0","article-title":"The effect of omeprazole (OME) 20 mg and 10 mg daily on heartburn in patients with endoscopy negative reflux disease (ENRD)","volume":"108","author":"Lind","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.01.014_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/00044011-199816010-00002","article-title":"Meta-analysis of cisapride, omeprazole and ranitidine in the treatment of GERD","volume":"1","author":"Iskedjian","year":"1998","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.cgh.2006.01.014_bib3","first-page":"1171","article-title":"Proton pump inhibitors in the treatment of gastro-oesophageal reflux disease","volume":"6","author":"Tolman","year":"2001","journal-title":"Exp Opin Pharmacother"},{"key":"10.1016\/j.cgh.2006.01.014_bib4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11938-000-0043-6","article-title":"Functional gastroesophageal reflux disease (GERD)","volume":"3","author":"DeVault","year":"2000","journal-title":"Curr Treatment Options Gastroenterology"},{"key":"10.1016\/j.cgh.2006.01.014_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2036.1996.44186000.x","article-title":"Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis","volume":"10","author":"Bate","year":"1996","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2006.01.014_bib6","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1365-2036.1997.00185.x","article-title":"Treating the symptoms of gastro-oesophageal reflux disease","volume":"11","author":"Galmiche","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2006.01.014_bib7","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3109\/00365529709011212","article-title":"Heartburn without esophagitis","volume":"32","author":"Lind","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.01.014_bib8","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1111\/j.1572-0241.1999.01206.x","article-title":"Quality of life in patients with heartburn but without esophagitis","volume":"94","author":"Havelund","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.01.014_bib9","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1046\/j.1365-2036.2000.00854.x","article-title":"The effect of tegaserod (HTF 919) on oesphageal acid exposure in gastro-oesophageal reflux disease","volume":"14","author":"Kahrilas","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2006.01.014_bib10","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJM199510263331703","article-title":"A comparison of five maintenance therapies for reflux esophagitis","volume":"333","author":"Vigneri","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2006.01.014_bib11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0014-2999(91)90821-7","article-title":"Prokinetic benzamides stimulate peristaltic activity in the isolated guinea pig ileum by activation of 5-HT4 receptors","volume":"205","author":"Buchheit","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.cgh.2006.01.014_bib12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF00176615","article-title":"SDZ 205-557, a selective, surmountable antagonist for 5-HT4 receptors in the isolated guinea pig ileum","volume":"345","author":"Buchheit","year":"1992","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.cgh.2006.01.014_bib13","first-page":"A506","article-title":"5-HT released by mucosal stimulation acts via 5-HT4 receptors to release the sensory transmitter CGRP and initiate the peristaltic reflex","volume":"106","author":"Grider","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.01.014_bib14","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0016-5085(98)70203-3","article-title":"5-Hydroxy-tryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine","volume":"115","author":"Grider","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.01.014_bib15","doi-asserted-by":"crossref","first-page":"A600","DOI":"10.1016\/0016-5085(95)26712-3","article-title":"The peristaltic reflex induced by mucosal stimuli in human and guinea pig intestine is mediated by distinct mucosal 5-HT receptors","volume":"108","author":"Foxx-Orenstein","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.01.014_bib16","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1046\/j.1365-2036.2001.01103.x","article-title":"Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects","volume":"15","author":"Degen","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2006.01.014_bib17","first-page":"459","article-title":"Modulation of rectal spinal afferent sensitivity via 5-HT4 receptors","volume":"10","author":"Mathis","year":"1998","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2006.01.014_bib18","series-title":"Rome II","author":"Drossman","year":"2000"},{"key":"10.1016\/j.cgh.2006.01.014_bib19","series-title":"The design and analysis of clinical experiments","author":"Fleiss","year":"1986"},{"key":"10.1016\/j.cgh.2006.01.014_bib20","series-title":"Statistics in the pharmaceutical industry","first-page":"193","article-title":"Crossover designs in medical research","author":"Fisher","year":"1994"},{"key":"10.1016\/j.cgh.2006.01.014_bib21","series-title":"Encyclopedia of biostatistics","first-page":"1033","article-title":"Crossover designs","author":"Senn","year":"1998"},{"key":"10.1016\/j.cgh.2006.01.014_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-2125.2002.01612.x","article-title":"Serotonergic modulating drugs for functional gastrointestinal diseases","volume":"54","author":"Spiller","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.cgh.2006.01.014_bib23","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.3748\/wjg.v10.i19.2836","article-title":"Tegaserod inhibits noxious rectal distention induced response and limbic system c-FOS expression in rats with visceral hypersensitivity","volume":"10","author":"Jiao","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.01.014_bib24","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.3748\/wjg.v10.i12.1830","article-title":"Effects of tegaserod on Fos, substance P and calcitonin gene-related peptide expression induced by colon inflammation in lumbarsacral spinal cord","volume":"10","author":"Sun","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.01.014_bib25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1365-2982.2002.00328.x","article-title":"Serotonin type-4 receptors modulate the sensitivity of intramural mechanoreceptive afferents of the cat rectum","volume":"14","author":"Schikowski","year":"2002","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2006.01.014_bib26","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1046\/j.1365-2036.2003.01449.x","article-title":"Tegaserod, a 5-HT4 receptor partial agonist, decreases sensitivity to rectal distention in healthy subjects","volume":"17","author":"Coffin","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2006.01.014_bib27","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1046\/j.1365-2036.2003.01775.x","article-title":"Influence of tegaserod on proximal gastric tone and on the perception of gastric distention","volume":"18","author":"Tack","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2006.01.014_bib28","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/gut.52.5.671","article-title":"An Asia-Pacific, double blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome","volume":"53","author":"Kellow","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2006.01.014_bib29","first-page":"310","article-title":"Subject\u2019s global assessment of relief","volume":"56","author":"Muller-Lissner","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cgh.2006.01.014_bib30","first-page":"21","article-title":"Efficacy and tolerability of tegaserod in constipation dominant irritable bowel syndrome","volume":"14","author":"Shah","year":"2004","journal-title":"J Coll Phys Surg Pak"},{"key":"10.1016\/j.cgh.2006.01.014_bib31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/00365520310006748","article-title":"A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome","volume":"39","author":"Nyhlin","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.01.014_bib32","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1365-2036.2004.02217.x","article-title":"A single dose of Ranitidine 150 mg modulates esophageal acid sensitivity in patients with functional heartburn","volume":"20","author":"Rodriguez-Stanley","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2006.01.014_bib33","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0016-5085(98)70014-9","article-title":"Differential effects of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans","volume":"115","author":"Fass","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.01.014_bib34","first-page":"A72","article-title":"Wide spectrum of symptoms produced by barostat balloon distention of the esophagus in patients presenting with varied upper GI complaints","volume":"97","author":"Rodriguez-Stanley","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.01.014_bib35","first-page":"A115","article-title":"Are patients with functional heartburn sensitive to both mechanical and chemical stimuli?","volume":"97","author":"Rodriguez-Stanley","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.01.014_bib36","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2036.1996.44186000.x","article-title":"Reflux symptoms relief with omeprazole in patients without unequivocal oesophagitis","volume":"10","author":"Bate","year":"1996","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2006.01.014_bib37","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1365-2036.1997.00185.x","article-title":"Treating the symptoms of gastro-oesophageal reflux disease","volume":"11","author":"Galmiche","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2006.01.014_bib38","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3109\/00365529709011212","article-title":"Heartburn without esophagitis","volume":"32","author":"Lind","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.01.014_bib39","first-page":"A73","article-title":"Barostat balloon distention of the esophagus","volume":"97","author":"Rodriguez-Stanley","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.01.014_bib40","first-page":"A323","article-title":"Reliability of esophageal balloon distention and Bernstein measurements in patients with functional heartburn","volume":"126","author":"Rodriguez-Stanley","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.01.014_bib41","first-page":"310","article-title":"Subject\u2019s global assessment of relief","volume":"56","author":"Muller-Lissner","year":"2003","journal-title":"J Clin Epidemiol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356506000814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356506000814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:57:10Z","timestamp":1761541030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356506000814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S1542356506000814"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2006.01.014","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Tegaserod on Esophageal Pain Threshold, Regurgitation, and Symptom Relief in Patients With Functional Heartburn and Mechanical Sensitivity","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2006.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Gastroenterological Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}